Apbiocode
Long Beach, US · Founded 2008 · 75 employees on LinkedIn · 1 known investors
Applied BioCode develops multiplex diagnostic testing products for infectious disease detection using proprietary barcoded magnetic bead technology. The company serves clinical and research markets with panels that detect bacterial and fungal pathogens and antimicrobial resistance markers.
Founders & leadership
Apbiocode was founded in 2008 by Winston Z. Ho, Ph.D..
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $120.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Apbiocode do?
- Applied BioCode develops multiplex diagnostic testing products for infectious disease detection using proprietary barcoded magnetic bead technology. The company serves clinical and research markets with panels that detect bacterial and fungal pathogens and antimicrobial resistance markers.
- Who founded Apbiocode?
- Apbiocode was founded by Winston Z. Ho, Ph.D. in 2008.
- Who are Apbiocode's investors?
- Apbiocode's investors include GRC Sinogreen.
- Where is Apbiocode headquartered?
- Apbiocode is headquartered in Long Beach, US.